# Medix Pharmaceuticals Americas, Inc.

- Location (FDA's records): Washington, DC
- FDA decisions: 1 (1997–1997): 1 510(k) clearance
- Product codes: MGQ (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 13 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Midlothian Laboratories: 2 (https://510kreport.com/company/midlothian-laboratories)
- Ferndale Laboratories, Inc.: 1 (https://510kreport.com/company/ferndale-laboratories)
- Dermal Life, LLC: 1 (https://510kreport.com/company/dermal-life)
- Pierre Fabre Medical Devices: 1 (https://510kreport.com/company/pierre-fabre-medical-devices)
- Sinclair Pharmaceuticals, Ltd.: 1 (https://510kreport.com/company/sinclair-pharmaceuticals)
- Valeant Pharmaceuticals: 1 (https://510kreport.com/company/valeant-pharmaceuticals)
- Ceragenix Corporation: 1 (https://510kreport.com/company/ceragenix)
- Stiefel Laboratories, Inc.: 1 (https://510kreport.com/company/stiefel-laboratories)

## Its most-cited devices
- K964240: Biafine Wound Dressing Emulsion (1997), cited by 13

## Recent decisions
- K964240: Biafine Wound Dressing Emulsion (Jan 22, 1997)

Source page: https://510kreport.com/company/medix-pharmaceuticals-americas